Metraipolis › archive › dc_e463af96162c

Cryo-EM structure-based discovery of etravirine as a specific inhibitor of PRMT5/pICln protein-protein interaction for prostate cancer treatment — Europe PMC PMID:42710907

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42710907
DOI
10.1080/14756366.2026.2727844
License (as archived)
solo-consultazione
Archived
2026-10-15T22:55:34.965Z
SHA-256 of the archived text
bb2258028a065c4aac6cf5eadab46f4ad2e325704a113a2424dd310ce57d2e08
Stable URL of this page
https://metraipolis.com/documento/dc_e463af96162c

How to cite

Cryo-EM structure-based discovery of etravirine as a specific inhibitor of PRMT5/pICln protein-protein interaction for prostate cancer treatment — Europe PMC PMID:42710907 — Europe PMC (en), https://europepmc.org/article/MED/42710907 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e463af96162c (Metraipolis archive dc_e463af96162c, sha256 bb2258028a065c4aac6cf5eadab46f4ad2e325704a113a2424dd310ce57d2e08)
BibTeX
@misc{dce463af96162c,
  title = {Cryo-EM structure-based discovery of etravirine as a specific inhibitor of PRMT5/pICln protein-protein interaction for prostate cancer treatment — Europe PMC PMID:42710907},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42710907},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e463af96162c; sha256 bb2258028a065c4aac6cf5eadab46f4ad2e325704a113a2424dd310ce57d2e08},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42710907. Agents can read the archived copy with the MCP tool read_document.